Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (44)
Chin-Hsiao Tseng. (2023) Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients. Pharmaceuticals 16:5, pages 679.
Crossref
Crossref
Yuhong Luo, Cen Xie, Chad N. Brocker, Jie Fan, Xuan Wu, Lijin Feng, Qiong Wang, Jie Zhao, Dasheng Lu, Mayank Tandon, Maggie Cam, Kristopher W. Krausz, Weiwei Liu & Frank J. Gonzalez. (2019) Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6. Gastroenterology 157:3, pages 744-759.e4.
Crossref
Crossref
Elena Popa, Florin Zugun-Eloae, Mihaela Zlei, Maria Traian, Agnes Bacusca, Andrei Emilian Popa & Adorata Elena Coman. (2019) Peroxisome Proliferator-Activated Receptors - Alpha in Chronic Inflammation - Mini-Review. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 12, pages 1-11.
Crossref
Crossref
Yangyang Ji, Hui Li, Fang Wang & Linglan Gu. (2018) PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis. Frontiers in Pharmacology 9.
Crossref
Crossref
Tony Tong-Lin Wu, Yat-Ching Tong, I-Hung Chen, Ho-Shan Niu, Yingxiao Li & Juei-Tang Cheng. (2018) Induction of apoptosis in prostate cancer by ginsenoside Rh2. Oncotarget 9:13, pages 11109-11118.
Crossref
Crossref
Mani Roshan-Moniri, Michael Hsing, Miriam S. Butler, Artem Cherkasov & Paul S. Rennie. (2014) Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers. Cancer Treatment Reviews 40:10, pages 1137-1152.
Crossref
Crossref
Carmine Stolfi, Veronica De Simone, Francesco Pallone & Giovanni Monteleone. (2013) Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer. International Journal of Molecular Sciences 14:9, pages 17972-17985.
Crossref
Crossref
Jihan A. Youssef & Mostafa Z. BadrJihan A. Youssef & Mostafa Z. Badr. 2013. Peroxisome Proliferator-Activated Receptors. Peroxisome Proliferator-Activated Receptors
33
69
.
Jihan Youssef & Mostafa Z. Badr. 2013. Peroxisome Proliferator-Activated Receptors (PPARs). Peroxisome Proliferator-Activated Receptors (PPARs)
1
6
.
Takuji Tanaka. (2012) Preclinical Cancer Chemoprevention Studies Using Animal Model of Inflammation-Associated Colorectal Carcinogenesis. Cancers 4:3, pages 673-700.
Crossref
Crossref
Carmine Stolfi, Francesco Pallone & Giovanni Monteleone. (2012) Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives. Journal of Biomedicine and Biotechnology 2012, pages 1-6.
Crossref
Crossref
Alessandra Fucci, Tommaso Colangelo, Carolina Votino, Massimo Pancione, Lina Sabatino & Vittorio Colantuoni. (2012) The Role of Peroxisome Proliferator-Activated Receptors in the Esophageal, Gastric, and Colorectal Cancer. PPAR Research 2012, pages 1-9.
Crossref
Crossref
MAO SONG LIN, JUN XING HUANG, WEI CHANG CHEN, BAO FENG ZHANG, JING FANG, QIONG ZHOU, YING HU & HENG JUN GAO. (2011) Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology. Oncology Letters 2:6, pages 1219-1224.
Crossref
Crossref
Jennifer E. Foreman, Wen‐Chi L. Chang, Prajakta S. Palkar, Bokai Zhu, Michael G. Borland, Jennie L. Williams, Lance R. Kramer, Margie L. Clapper, Frank J. Gonzalez & Jeffrey M. Peters. (2011) Functional characterization of peroxisome proliferator‐activated receptor‐β/δ expression in colon cancer. Molecular Carcinogenesis 50:11, pages 884-900.
Crossref
Crossref
Jihan Youssef & Mostafa Badr. (2011) Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. British Journal of Pharmacology 164:1, pages 68-82.
Crossref
Crossref
Markus Meissner, Barbara Berlinski, Monika Doll, Igor Hrgovic, Vesselina Laubach, Gabi Reichenbach, Stefan Kippenberger, Jens Gille & Roland Kaufmann. (2011) AP1-dependent repression of TGFα-mediated MMP9 upregulation by PPARδ agonists in keratinocytes. Experimental Dermatology 20:5, pages 425-429.
Crossref
Crossref
Jeffrey M. Peters & Frank J. Gonzalez. 2011. Signaling Pathways in Squamous Cancer. Signaling Pathways in Squamous Cancer
223
240
.
Gitte Pedersen & Jørn Brynskov. (2010) Topical Rosiglitazone Treatment Improves Ulcerative Colitis by Restoring Peroxisome Proliferator-Activated Receptor-γ Activity. American Journal of Gastroenterology 105:7, pages 1595-1603.
Crossref
Crossref
Khanh vinh quoc Luong & Lan Thi Hoang Nguyen. (2010) The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Critical Reviews in Oncology/Hematology 73:3, pages 192-201.
Crossref
Crossref
Laurianne Van Landeghem, Maxime M Mahé, Raluca Teusan, Jean Léger, Isabelle Guisle, Rémi Houlgatte & Michel Neunlist. (2009) Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics 10:1.
Crossref
Crossref
Jie Zhou, Wei Zhang, Bing Liang, Mathew C. Casimiro, Diana Whitaker-Menezes, Min Wang, Michael P. Lisanti, Susan Lanza-Jacoby, Richard G. Pestell & Chenguang Wang. (2009) PPARγ activation induces autophagy in breast cancer cells. The International Journal of Biochemistry & Cell Biology 41:11, pages 2334-2342.
Crossref
Crossref
Manuela Oraldi, Antonella Trombetta, Fiorella Biasi, Rosa A. Canuto, Marina Maggiora & Giuliana Muzio. (2009) Decreased Polyunsaturated Fatty Acid Content Contributes to Increased Survival in Human Colon Cancer. Journal of Oncology 2009, pages 1-9.
Crossref
Crossref
Alexander Tenenbaum, Valentina Boyko, Enrique Z Fisman, Ilan Goldenberg, Yehuda Adler, Micha S Feinberg, Michael Motro, David Tanne, Joseph Shemesh, Ehud Schwammenthal & Solomon Behar. (2008) Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?. Cardiovascular Diabetology 7:1.
Crossref
Crossref
Weiwei Shan, Prajakta S. Palkar, Iain A. Murray, Emily I. McDevitt, Mary J. Kennett, Boo Hyon Kang, Harriet C. Isom, Gary H. Perdew, Frank J. Gonzalez & Jeffrey M. Peters. (2008) Ligand Activation of Peroxisome Proliferator–Activated Receptor β/δ (PPARβ/δ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression. Toxicological Sciences 105:2, pages 418-428.
Crossref
Crossref
Weidong Su, Brian M. Necela, Kosaku Fujiwara, Shinichi Kurakata, Nicole R. Murray, Alan P. Fields & E. Aubrey Thompson. (2008) The high affinity peroxisome proliferator‐activated receptor‐gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane‐treated mice. International Journal of Cancer 123:5, pages 991-997.
Crossref
Crossref
Jeffrey M. PetersHolly E. HollingsheadFrank J. Gonzalez. (2008) Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease. Clinical Science 115:4, pages 107-127.
Crossref
Crossref
Carmine Stolfi, Roberto Pellegrini, Eleonora Franzè, Francesco Pallone & Giovanni Monteleone. (2008) Molecular basis of the potential of mesalazine to prevent colorectal cancer. World Journal of Gastroenterology 14:28, pages 4434.
Crossref
Crossref
Giuseppina Barrera, Cristina Toaldo, Stefania Pizzimenti, Angelo Cerbone, Piergiorgio Pettazzoni, Mario Umberto Dianzani & Carlo Ferretti. (2008) The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR Research 2008, pages 1-15.
Crossref
Crossref
Holly E. Hollingshead, Michael G. Borland, Andrew N. Billin, Timothy M. Willson, Frank J. Gonzalez & Jeffrey M. Peters. (2008) Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 29:1, pages 169-176.
Crossref
Crossref
Elizabeth E. Girroir, Holly E. Hollingshead, Andrew N. Billin, Timothy M. Willson, Gavin P. Robertson, Arun K. Sharma, Shantu Amin, Frank J. Gonzalez & Jeffrey M. Peters. (2008) Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology 243:1-2, pages 236-243.
Crossref
Crossref
Weiwei Shan, Christopher J. Nicol, Shinji Ito, Moses T. Bility, Mary J. Kennett, Jerrold M. Ward, Frank J. Gonzalez & Jeffrey M. Peters. (2007) Peroxisome proliferator-activated receptor-β/δ protects against chemically induced liver toxicity in mice. Hepatology 47:1, pages 225-235.
Crossref
Crossref
Holly E. Hollingshead, Renee L. Killins, Michael G. Borland, Elizabeth E. Girroir, Andrew N. Billin, Timothy M. Willson, Arun K. Sharma, Shantu Amin, Frank J. Gonzalez & Jeffrey M. Peters. (2007) Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines. Carcinogenesis 28:12, pages 2641-2649.
Crossref
Crossref
Cynthia Lee Richard, Erica Lauren Lowthers & Jonathan Blay. (2007) 15-Deoxy-Δ12,14-prostaglandin J2 down-regulates CXCR4 on carcinoma cells through PPARγ- and NFκB-mediated pathways. Experimental Cell Research 313:16, pages 3446-3458.
Crossref
Crossref
E. Aubrey Thompson. (2007) PPARγ Physiology and Pathology in Gastrointestinal Epithelial Cells. Molecules and Cells 24:2, pages 167-176.
Crossref
Crossref
Stamatios Theocharis, Costas Giaginis, Aikaterini Parasi, Alexandra Margeli, John Kakisis, Emmanuel Agapitos & Gregorios Kouraklis. (2007) Expression of Peroxisome Proliferator-Activated Receptor-γ in Colon Cancer: Correlation with Histopathological Parameters, Cell Cycle-Related Molecules, and Patients’ Survival. Digestive Diseases and Sciences 52:9, pages 2305-2311.
Crossref
Crossref
Weidong Su, Craig R. Bush, Brian M. Necela, Shelly R. Calcagno, Nicole R. Murray, Alan P. Fields & E. Aubrey Thompson. (2007) Differential expression, distribution, and function of PPAR-γ in the proximal and distal colon. Physiological Genomics 30:3, pages 342-353.
Crossref
Crossref
Annika Gustafsson, Elisabeth Hansson, Ulf Kressner, Svante Nordgren, Marianne Andersson, Wenhua Wang, Christina Lönnroth & Kent Lundholm. (2007)
EP
1–4
subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease‐specific mortality
. International Journal of Cancer 121:2, pages 232-240.
Crossref
Crossref
Andrew D. Burdick, Moses T. Bility, Elizabeth E. Girroir, Andrew N. Billin, Timothy M. Willson, Frank J. Gonzalez & Jeffrey M. Peters. (2007) Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes. Cellular Signalling 19:6, pages 1163-1171.
Crossref
Crossref
Han–Mo Chiu, Jaw–Town Lin, Chia–Tung Shun, Jin–Tung Liang, Yi–Chia Lee, Shih–Pei Huang & Ming–Shiang Wu. (2007) Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm. Clinical Gastroenterology and Hepatology 5:2, pages 221-229.
Crossref
Crossref
G. Martinasso, M. Oraldi, A. Trombetta, M. Maggiora, O. Bertetto, R. A. Canuto & G. Muzio. (2007) Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines. PPAR Research 2007, pages 1-9.
Crossref
Crossref
Christen A. McAlpine, Yaacov Barak, Ilze Matise & Robert T. Cormier. (2006)
Intestinal‐specific PPARγ deficiency enhances tumorigenesis in Apc
Min/+
mice
. International Journal of Cancer 119:10, pages 2339-2346.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
E. F. STANGE. (2006) Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 24:s3, pages 64-67.
Crossref
Crossref
Marjorie A. Peraza, Andrew D. Burdick, Holly E. Marin, Frank J. Gonzalez & Jeffrey M. Peters. (2006) The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR). Toxicological Sciences 90:2, pages 269-295.
Crossref
Crossref